Dr. De-Min ZHU, an expert in nanotechnology for drug delivery of both small molecules and biological molecules for the treatment of cancer, infectious and other diseases, was invited to the Chinese Academy of Sciences' Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), where he spoke about “Key R&D Advances at Cureport” on Dec 25. 

Dr. ZHU is also the president & CEO of a growing US pharmaceutical company Cureport, Inc., which has made a revolutionary breakthrough to the manufacture of liposomal products through an innovative controlled self-assembly process. 

Prof. LIU Huizhou, director general of QIBEBT, warmly welcomed the guests. The host of the lecture was Prof. LIANG Xiangfeng, deputy director of Science and  Technology Department of QIBEBT. Dr. ZHU introduced the status quo of nanomedicine, framework of Cureport, breakthrough in liposomal formulations and their clinical efficacy to cure various cancers/diseases, and how to integrate research, production and medical application. Scientists working on chiral products synthesis and bio-preparation of capsules for medicine at QIBEBT presented their research results and had a good discussion with Dr. Zhu.  

The visit is expected to facilitate potential collaboration between Cureport and QIBEBT.